Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

281 questions in 50 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

current versions

No studies 281 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
iMRI image‐guided surgery vs standard surgery Adverse events · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
Neuronavigation image‐guided surgery vs standard surgery Overall survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
Neuronavigation image‐guided surgery vs standard surgery Progression‐free survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
Neuronavigation image‐guided surgery vs standard surgery Quality of life · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
iMRI image‐guided surgery vs standard surgery Overall survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
iMRI image‐guided surgery vs standard surgery Progression‐free survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
iMRI image‐guided surgery vs standard surgery Quality of life · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
5‐ALA image‐guided surgery vs standard surgery Adverse events · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
5‐ALA image‐guided surgery vs standard surgery Overall survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
5‐ALA image‐guided surgery vs standard surgery Progression‐free survival · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
5‐ALA image‐guided surgery vs standard surgery Quality of life · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
Neuronavigation image‐guided surgery vs standard surgery Adverse events · high‐grade glioma Intraoperative imaging technology to maximise extent of resection for glioma (2018) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Disease‐free survival · people with non‐rhabdomyosarcoma soft tissue sarcoma Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Non‐hematologic toxicity grade 3 to 4 · people with non‐rhabdomyosarcoma soft tissue sarcoma Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Health‐related quality of life · people with non‐rhabdomyosarcoma soft tissue sarcoma Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma… (2017) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Length of time with fever ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Number of days on therapeutic antibiotics ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Number of adverse events requiring discontinuation of treatment ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Quality of life ‐ not reported · treating infections in people with neutropenia or neutrophil dysfunction Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Severe adverse effects (G3/4) outcomes · Women with newly diagnosed epithelial ovarian cancer Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer (2016) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Adverse events · women with stage I/II epithelial ovarian cancer Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer (2015) · Cochrane	no estimate extracted	NR	No studies
Intervention NR People with serious adverse events · people with neutropenia or neutrophil dysfunction Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction (2015) · Cochrane	no estimate extracted	NR	No studies
Dance/movement therapy vs standard care CI: Confidence interval · patients with improving psychological and physical outcomes in cancer patients Dance/movement therapy for improving psychological and physical outcomes in cancer patients (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs placebo Pain ‐ Any grade · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs placebo Dose reductions · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs cidofovir Pain ‐ Any grade · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs cidofovir Fatigue ‐ Any grade · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs cidofovir Headache ‐ Any grade · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Summary of findings for imiquimod vs cidofovir Treatment discontinuation · women with high‐grade VIN Medical interventions for high‐grade vulval intraepithelial neoplasia (2015) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Recurrence rate at 1 year · women with high‐grade VIN Surgical interventions for high‐grade vulval intraepithelial neoplasia (2014) · Cochrane	no estimate extracted	NR	No studies
Image guided surgery vs standard surgery Complete resection ‐ iMRI · high grade glioma Image guided surgery for the resection of brain tumours (2014) · Cochrane	no estimate extracted	NR	No studies